Testing effectiveness (Phase 2)Not Yet RecruitingNCT05504187
What this trial is testing
Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus
Who this might be right for
Systemic Lupus Erythematosus
Kira Pharmacenticals (US), LLC. 24